VAMP-1 associated congenital myasthenic syndrome: a demonstrative case with response to low-dose pyridostigmine

Long-Term Efficacy of Non-steroid Immunosuppressive Agents in Anti-Muscle-Specific Kinase Positive Myasthenia Gravis Patients: A Prospective Study